CPT Code Overview

CPT 96415 describes chemotherapy administration using an intravenous infusion technique for each additional hour, billed in addition to the primary infusion code. This add‑on code applies when an infusion extends beyond the time covered by the initial hour and is intended for administration of chemotherapy or other highly complex drugs or biologic agents.

Service Type: Injection and Intravenous Infusion Chemotherapy and Other Highly Complex Drug or Highly Complex Biologic Agent Administration

Typical Site of Service: Infusion center or outpatient facility, commonly submitted alongside the initial infusion code CPT 96413 when treatment duration exceeds the first hour.

Clinical Context

A 62-year-old patient with metastatic colon cancer (diagnosis C18.9) receives outpatient intravenous chemotherapy in an infusion center. The oncology nurse initiates the primary infusion coded as 96413 for the first hour of a chemotherapy agent. The patient’s regimen requires a prolonged infusion, so after the initial hour the nurse documents continued infusion time in one-hour increments. Each additional hour beyond the first hour is reported using the add-on code 96415. The treatment encounter includes medication preparation, IV access verification, infusion rate monitoring, vital signs, and documentation of any infusion-related reactions. Reimbursement submission commonly pairs 96413 (initial hour) with one or more units of 96415 to reflect the extended infusion time.

Coding Specifications

• Modifiers listed:

• 59 - Distinct Procedural Service

• Use when a separate and distinct chemotherapy-related procedural service, unrelated to the primary infusion time, is performed at the same encounter and needs to be identified as distinct for billing purposes.

• 76 - Repeat Procedure or Service by Same Physician or Other Qualified Health Care Professional

• Use when the same clinician repeats the identical infusion service within the same day for the same patient (for example, if an infusion is stopped and later restarted and the payer requires reporting of the repeat service).

• Associated provider taxonomies and specialties:

• 207RH0003X — Hematology & Oncology Physician

• 207RX0202X — Medical Oncology Physician

• 2085R0202X — Radiation Oncology Physician

• Notes on usage:

• 96415 is an add-on code reported in addition to the primary infusion code 96413 to capture each additional hour of intravenous chemotherapy administration.

• Do not append additional modifiers beyond those listed unless payer policy or other documentation explicitly supports their use for the specific claim.

Related Diagnoses

• C50.911 — Malignant neoplasm of unspecified site of right female breast

• Relevance: Breast cancer may be treated with intravenous chemotherapy regimens administered in an outpatient infusion center; 96415 can be used when infusions extend beyond the initial hour.

• C34.90 — Malignant neoplasm of unspecified part of unspecified bronchus or lung

• Relevance: Lung cancer patients frequently receive IV chemotherapy or combination systemic therapy requiring prolonged infusion times documented with add-on hours using 96415.

• C18.9 — Malignant neoplasm of colon, unspecified

• Relevance: Colorectal malignancies commonly require multi-agent IV chemotherapy delivered in outpatient infusions; extended infusion time beyond the first hour is captured with 96415.

• C61 — Malignant neoplasm of prostate

• Relevance: Advanced prostate cancer regimens that include IV chemotherapeutic agents may necessitate extended infusion time reported with 96415 when applicable.

• C25.9 — Malignant neoplasm of pancreas, unspecified

• Relevance: Pancreatic cancer systemic chemotherapy often requires IV infusion; additional hourly units reported with 96415 document prolonged administration.

Related CPT Codes

• 96413 - Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug

• Relationship: 96413 is the primary initial infusion code for the first hour. 96415 is reported in addition to 96413 for each additional hour of the same infusion.

• 96417 - Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (list separately in addition to code for primary procedure)

• Relationship: 96417 is used when a different chemotherapy agent or biologic is infused sequentially during the same encounter. It is reported separately from 96413 and may be reported along with 96415 when additional hours are required for a subsequent, different infusion.

• Common combinations and workflow:

• Initial hour: report 96413.

• Continued same-substance infusion: append one or more units of 96415 for each additional hour beyond the initial hour.

• Sequential, different substance: report 96417 for each additional different drug infusion (up to 1 hour each), with 96415 used if any of those sequential infusions exceed the first hour for that substance.

National commercial mean rates for CPT 96415 (BUCA representing the commercial benchmark) are substantially higher than Medicare. The BUCA mean of $45.37 compares with Medicare at $29.45, indicating Medicare reimbursements sit roughly $15.92 below the commercial aggregate mean.

Dispersion varies across payers. Cigna shows the widest interquartile spread (P75–P25 = $25.80), followed by UnitedHealth Group and Blue Cross Blue Shield, while Medicare is the tightest (P75–P25 = $4.00). The table and bar chart below present the full payer breakdown of mean rates and percentiles.